Meyka AI API is live for developers.Start building.
Advertisement
Genetic Technologies Limited

Genetic Technologies Limited (GENE) Stock Overview

Explore Genetic Technologies Limited’s financial performance, market position, analyst ratings, and future outlook.

GENE●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.77
$0.00(0.00%)
U.S. Market opens in 54h 33m
Advertisement

Genetic Technologies Limited (GENE)

Meyka AI Score

Z

Key Financials

Market Cap111.2M
P/E Ratio-0.42
EPS (TTM)$-0.02
ROE-1.85%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

GENE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Genetic Technologies Limited (GENE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.42 and a market capitalization of 111.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.65%
5-Day Change
-0.65%
1-Month Change
-0.65%
3-Month Change
-4.49%
6-Month Change
-57.97%
Year-to-Date (YTD) Change
-70.35%
1-Year Change
-75.48%
3-Year Change
-92.50%
5-Year Change
-92.92%
All-Time (Max) Change
-99.93%

Contact Information

https://www.gtglabs.com
61 3 8412 7000
60-66 Hanover Street, Fitzroy, VIC, 3065

Company Facts

550 Employees
IPO DateSep 6, 2005
CountryAU

Frequently Asked Questions